{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T15:12:42Z","timestamp":1719933162863},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","surgpath.theclinics.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.path.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T05:02:13Z","timestamp":1464411733000},"page":"307-328","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers"],"prefix":"10.1016","volume":"9","author":[{"given":"Patricia A.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blaise A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/j.path.2016.02.002_bib1","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.path.2016.02.002_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","article-title":"Histopathologic features of genetically determined ovarian cancer","volume":"21","author":"Shaw","year":"2002","journal-title":"Int J Gynecol Pathol"},{"issue":"7353","key":"10.1016\/j.path.2016.02.002_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.path.2016.02.002_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv214","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.path.2016.02.002_bib5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.path.2016.02.002_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1055-9965.EPI-07-2703","article-title":"A\u00a0prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study","volume":"17","author":"Greene","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"10.1016\/j.path.2016.02.002_bib7","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.29321","article-title":"Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer","volume":"121","author":"Walker","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2016.02.002_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.path.2016.02.002_bib9","doi-asserted-by":"crossref","first-page":"2197.e1","DOI":"10.1053\/j.gastro.2010.04.024","article-title":"Report from the Jerusalem workshop on Lynch syndrome\u2014hereditary nonpolyposis colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.path.2016.02.002_bib10","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1002\/cncr.28933","article-title":"Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing","volume":"120","author":"Ferguson","year":"2014","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.path.2016.02.002_bib11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1200\/JCO.2011.38.4719","article-title":"Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results","volume":"30","author":"Beamer","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.path.2016.02.002_bib12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","article-title":"The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy","volume":"38","author":"Chui","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"26","key":"10.1016\/j.path.2016.02.002_bib13","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7326\/0003-4819-155-2-201107190-00002","article-title":"Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis","volume":"155","author":"Ladabaum","year":"2011","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.path.2016.02.002_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J\u00a0Pathol"},{"issue":"Supp 1","key":"10.1016\/j.path.2016.02.002_bib17","first-page":"214A","article-title":"Mucosal epithelial proliferation and p53 overexpression are frequent in women with BRCA mutations","volume":"17","author":"Shaw","year":"2004","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"10.1016\/j.path.2016.02.002_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2016.02.002_bib23","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.path.2016.02.002_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/1940-6207.CAPR-15-0072","article-title":"The fallopian tube: from back stage to center stage","volume":"8","author":"Greene","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"8","key":"10.1016\/j.path.2016.02.002_bib25","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.humpath.2006.11.010","article-title":"Recommendations for the reporting of fallopian tube neoplasms","volume":"38","author":"Longacre","year":"2007","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.path.2016.02.002_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2016.02.002_bib27","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2016.02.002_bib28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.path.2016.02.002_bib30","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"issue":"29","key":"10.1016\/j.path.2016.02.002_bib32","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.path.2016.02.002_bib33","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"15","key":"10.1016\/j.path.2016.02.002_bib34","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.path.2016.02.002_bib35","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","article-title":"Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status","volume":"118","author":"Manchanda","year":"2011","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2016.02.002_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","article-title":"Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma","volume":"9","author":"Nik","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"10.1016\/j.path.2016.02.002_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib39","first-page":"49","article-title":"Early adenocarcinoma of the fallopian tubes. A case for multifocal tumorigenesis","volume":"3","author":"Bannatyne","year":"1981","journal-title":"Diagn Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00004347-200004000-00007","article-title":"Mucosal epithelial proliferation of the fallopian tube: prevalence, clinical associations, and optimal strategy for histopathologic assessment","volume":"19","author":"Yanai-Inbar","year":"2000","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.path.2016.02.002_bib41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2013evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J\u00a0Pathol"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2016.02.002_bib43","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.path.2016.02.002_bib45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","article-title":"Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications","volume":"29","author":"Carlson","year":"2010","journal-title":"Int J Gynecol Pathol"},{"issue":"12","key":"10.1016\/j.path.2016.02.002_bib46","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/his.12419","article-title":"Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal","volume":"65","author":"Singh","year":"2014","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.path.2016.02.002_bib48","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.path.2016.02.002_bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ygyno.2010.05.012","article-title":"Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers","volume":"118","author":"Vicus","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2014.01.018","article-title":"Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later","volume":"132","author":"Powell","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.path.2016.02.002_bib52","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/IGC.0b013e31823d1b5c","article-title":"Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?","volume":"22","author":"Reitsma","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A\u00a0candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J\u00a0Pathol"},{"issue":"22","key":"10.1016\/j.path.2016.02.002_bib54","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.path.2016.02.002_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.4263","article-title":"Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer","volume":"231","author":"Crum","year":"2013","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.path.2016.02.002_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAP.0b013e3181ecdee1","article-title":"A\u00a0pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube","volume":"17","author":"Mehrad","year":"2010","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000000293","article-title":"Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia","volume":"39","author":"Rabban","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2016.02.002_bib58","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","article-title":"Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis","volume":"35","author":"Kurman","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2016.02.002_bib59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J\u00a0Pathol"},{"issue":"4","key":"10.1016\/j.path.2016.02.002_bib60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/his.12580","article-title":"Microscopic extraovarian sex cord proliferations: an undescribed phenomenon","volume":"66","author":"McCluggage","year":"2015","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/his.12386","article-title":"Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing","volume":"65","author":"Downes","year":"2014","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2016.02.002_bib62","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/PAS.0b013e3182796e27","article-title":"Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome","volume":"37","author":"Karamurzin","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2016.02.002_bib63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ygyno.2008.08.002","article-title":"Synchronous occult cancers of the endometrium and fallopian tube in an MSH2 mutation carrier at time of prophylactic surgery","volume":"111","author":"Palma","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"5 Pt 2","key":"10.1016\/j.path.2016.02.002_bib64","first-page":"1152","article-title":"Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer","volume":"102","author":"Chung","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.path.2016.02.002_bib65","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/PGP.0b013e31824a1dad","article-title":"Are women with endocervical adenocarcinoma at risk for Lynch syndrome? Evaluation of 101 cases including unusual subtypes and lower uterine segment tumors","volume":"31","author":"Mills","year":"2012","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.path.2016.02.002_bib66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2005.12.032","article-title":"Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients","volume":"102","author":"Pistorius","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.path.2016.02.002_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","article-title":"Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines","volume":"33","author":"Stoffel","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"36","key":"10.1016\/j.path.2016.02.002_bib69","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1200\/JCO.2008.18.6296","article-title":"Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome","volume":"26","author":"Westin","year":"2008","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918116000234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918116000234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T08:26:36Z","timestamp":1600676796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918116000234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1875918116000234"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2016.02.002","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}